No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs12521791 |
chr5:147442199-147442200 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs140230988 |
chr5:147442210-147442211 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs150318096 |
chr5:147442274-147442275 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs541062114 |
chr5:147442282-147442283 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs137926652 |
chr5:147442311-147442312 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs114697189 |
chr5:147442328-147442329 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs374496568 |
chr5:147442363-147442364 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs566497827 |
chr5:147442379-147442380 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs563162492 |
chr5:147442386-147442387 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs3822744 |
chr5:147442419-147442420 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
11 |
rs548872237 |
chr5:147442431-147442432 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs570683407 |
chr5:147442434-147442435 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs534609684 |
chr5:147442493-147442494 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs546999432 |
chr5:147442528-147442529 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs192222182 |
chr5:147442534-147442535 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs199645225 |
chr5:147442553-147442554 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs539149849 |
chr5:147442620-147442621 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs560895830 |
chr5:147442639-147442640 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs557463371 |
chr5:147442686-147442687 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs149023598 |
chr5:147442704-147442705 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs536802786 |
chr5:147442705-147442706 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs146906352 |
chr5:147442735-147442736 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs3756688 |
chr5:147442779-147442780 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
24 |
rs573530503 |
chr5:147442829-147442830 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs370779830 |
chr5:147442848-147442849 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs3834267 |
chr5:147442849-147442850 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs375189968 |
chr5:147442850-147442851 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs183821034 |
chr5:147442864-147442865 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs1423007 |
chr5:147442868-147442869 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
30 |
rs139295237 |
chr5:147442885-147442886 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs544704630 |
chr5:147442949-147442950 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs531923375 |
chr5:147442963-147442964 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs143310553 |
chr5:147442979-147442980 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs79977837 |
chr5:147443021-147443022 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs77190889 |
chr5:147443055-147443056 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs112464439 |
chr5:147443121-147443122 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs548812741 |
chr5:147443146-147443147 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs560897119 |
chr5:147443165-147443166 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs528419581 |
chr5:147443232-147443233 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs147099496 |
chr5:147443285-147443286 |
Weak transcription Enhancers
|
CpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs571638346 |
chr5:147443310-147443311 |
Weak transcription Enhancers
|
CpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs538988568 |
chr5:147443333-147443334 |
Weak transcription Enhancers
|
CpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs77532553 |
chr5:147443337-147443338 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs370073332 |
chr5:147443348-147443349 |
Weak transcription Enhancers
|
CpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs2287774 |
chr5:147443360-147443361 |
Weak transcription Enhancers
|
CpG island
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
46 |
rs536743284 |
chr5:147443402-147443403 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs116458106 |
chr5:147443417-147443418 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs2287773 |
chr5:147443443-147443444 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
49 |
rs534524887 |
chr5:147443452-147443453 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs558936827 |
chr5:147443532-147443533 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|